Skip to main content

Table 5 Clinicopathologic characteristics of gastric cancer with and without indication for adjuvant chemotherapy

From: Risk stratification for predicting postoperative recurrence of gastric cancer by grade of venous invasion

Parameters

Without AC indication

With AC indication

Recurrence

p value

Recurrence

p value

Yes (n = 7)

No (n = 95)

Yes (n = 31)

No (n = 24)

Age

 Median (range)

71 (70–86)

70 (42–92)

0.199

79 (42–96)

73 (55–84)

0.040

Sex

 Male/Female

7/0

63/32

0.095

23/8

18/6

1.000

Location

 Upper/Middle/Lower/extending in 2 or 3 regions

0/0/7/0

22/14/56/3

0.360

6/4/16/5

4/5/12/3

0.950

Surgery

 DG/TG/others

6/1/0

70/23/2

1.000

18/12/1

10/14/0

0.273

Lymph node dissection

 D1/D1+/D2

0/5/2

8/47/40

0.852

3/9/19

2/7/15

1.000

Synchronous multiple GCs

 Yes/No

2/5

9/86

0.165

2/29

4/20

0.387

Macroscopic type

 0/1/2/3/4/5

3/0/1/0/1/2

75/5/8/3/0/4

0.774

0/4/10/7/9/1

0/1/6/7/7/3

0.397

Histology

 pap tub1/tub2/muc/por sig nec

4/1/0/2

34/24/0/37

N.C

2/4/1/24

1/4/0/19

1.000

Depth of tumor invasion

 pT1/pT2/pT3

3/1/3

75/8/12

0.229

2/12/17

4/15/5

0.093

Cancer stromal volume

 med /int/sci/not described

0/4/2/1

3/43/10/39

0.947

0/14/17/0

2/11/9/2

0.551

Tumor infiltration pattern

 INFa/INFb/INFc/not described

0/5/2/0

3/46/18/28

1.000

1/11/19/0

0/8/15/1

1.000

VI grade

 v0/v1/v2/v3

1/2/2/2

58/27/7/3

0.064

0/14/8/9

6/11/7/0

0.012

Lymphatic invasion

 Yes/No

4/3

23/72

0.078

31/0

24/0

N.C

Nodal metastasis

 pN0/pN1/pN2

4/2/1

87/4/4

0.158

6/8/17

8/6/10

0.667

Resection margin status

 R0/R1/R2

7/0/0

94/1/0

1.000

25/5/1

23/1/0

0.591

pTNM stage

 I/II/III

3/4/0

79/16/0

0.026

0/6/25

0/8/16

0.350

Neoadjuvant chemotherapy

 Yes/No/unknown

0/7/0

0/83/12

N.C

1/28/2

1/22/1

1.000

Adjuvant chemotherapy

 Yes/No/unknown

4/3/0

9/74/12

0.008

19/7/5

20/3/1

0.299

  1. AC adjuvant chemotherapy, DG distal gastrectomy, TG total gastrectomy, GC gastric cancer, pap papillary adenocarcinoma, tub1 well-differentiated tubular adenocarcinoma, tub2 moderately differentiated tubular adenocarcinoma, muc mucinous adenocarcinoma, por poorly differentiated adenocarcinoma, either solid or poorly cohesive type, sig signet-ring cell carcinoma, nec neuroendocrine carcinoma, VI venous invasion, pTNM pathological tumor node metastasis, v0 no venous invasion, v1 1–3 invasions/slide, v2 4–6 invasions/slide, v3 no less than 7/slide. Filling type of venous invasion in macroscopically identifiable vein with a minor axis of ≥ 1 mm raised the grade of v1 or v2 by 1, N.C not calculated